You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股收評:科技股領跌大市 恆生科指跌近5% 恆指重挫541點

3月25日,港股午後跌幅持續擴大,恆指跌2.47%重挫541點,國指跌3.24%,恆生科技指數大幅收跌4.98%,再度跌破4400點關口。南下資金淨流出12.75億港元,大市成交額為1475億港元。

盤面上,大型科技股重挫領跌大市;互聯網醫療板塊跌幅最大,生物科技股、煙草概念股、體育用品股、汽車股、電力股、光伏股、半導體股、紙業股、金融股紛紛下挫,昨日強勢的餐飲股、教育股熄火,海底撈跌超7%。另一方面,香港本地股逆勢造好,六福集團、恆基地產、九龍倉置業均有漲幅,中信系多數上漲,中信銀行績後漲約4%。

具體來看

大型科技股重挫領跌大市,美團、快手跌超8%,阿里巴巴、京東、百度均跌超5%,網易跌4.88%,騰訊跌超2%。

汽車股普跌,蔚來-SW、長城汽車跌超7%,比亞迪股份跌超6%,廣汽集團、理想汽車-W、小鵬汽車、吉利汽車跌超3%。

最近,多家企業上調新能源汽車銷售價格,以應對原材料價格上漲。大摩3月24日發佈報吿,中國的碳酸鋰價格在過去一年中已經躍升了五倍,電動汽車電池製造商將需要提高近25%的價格;成本的轉嫁可能推動電動車製造商提價高達15%,並可能打擊需求。 東北證券認為,鋰期貨價格下跌僅反映個別貿易商的避險行為,鋰現貨價格仍堅挺,預計未來鋰價漲幅放緩,但將延續高位。

互聯網醫療板塊持續下挫,平安好醫生跌超10%,京東健康跌超11%,阿里健康得超9%。

CRO概念股集體下挫,金斯瑞生物、方達控股、藥明生物跌超8%,泰格醫藥、藥明康德、維亞生物跌超6%,昭衍新藥跌超4%。

內險股集體下跌,眾安在線跌超5%,中國太平跌超3%,中國平安、中國人壽、新華保險、中國太保跌超2%,中國人民保險、中國財險等跟跌。

中資券商股走低,中金公司、中信建投證券、東方證券跌超4%,招商證券、光大證券跌超3%。

煙草概念股集體下跌,中國波頓跌超8%,華寶國際、比亞迪電子跌超7%,思摩爾國際和中煙香港跌超4%。

教育股走低,思考樂教育跌超9%,天立教育跌超15%,新東方、新東方在線跌近5%。

海運板塊持續走低,海豐國際跌超7%,太平洋航運、東方海外國際、中遠海控跌超4%,中國外運跌超3%。

今日,南向資金淨流出12.74億港元,其中港股通(滬)淨流出5.16億港元,港股通(深)淨流出7.58億港元。

展望後市,方正證券研報認為,與以往情況類似,當前港股正處於經濟下行、貨幣環境收緊階段,新冠疫情的反覆、俄烏戰爭以及國際形勢的日趨嚴峻複雜這些內外部風險衝擊更是為港股市場增加了不確定性。不同的是,今年2月份以來港股的這一輪加速調整是在估值本身已經較低的情況下,再度出現的下跌。而在經歷這一輪下跌之後,港股市場目前已處在估值窪地、配置價值凸顯。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account